[Skip to Navigation]
July 2006

Uncertain Compassion in Using a Drug Before the Risks and Benefits Are Known

Author Affiliations

Author Affiliations: Department of Ophthalmology, University of California Irvine (Drs Narayanan and Kuppermann), and LV Prasad Eye Institute, Banjara Hills, Hyderabad, India (Dr Narayanan).

Arch Ophthalmol. 2006;124(7):1032-1034. doi:10.1001/archopht.124.7.1032

First, do no harm,” is a critical dictum in medical practice. Medical practitioners from ancient times to the present have used individual and shared scientific observations to determine the risks and benefits of individual therapies. However, the yield in this somewhat random process is certainly low. Since the development of the modern pharmaceutical industry as well as the Food and Drug Administration (FDA) as a regulatory agency, we as a medical and scientific community have been held to higher standards to provide proof of safety and efficacy of new treatments through randomized clinical trials.

Add or change institution